Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Innovation Pharmaceuticals Inc (IPIX)
OTHER OTC:IPIX
Holding IPIX?
Track your performance easily
IPIX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.02
Previous Close$0.01
Volume142.74K
Average Volume (3M)N/A
Market Cap
$104.14K
Enterprise Value-$521.86K
Total Cash (Recent Filing)$864.00K
Total Debt (Recent Filing)$238.00K
Price to Earnings (P/E)―
Beta-7.09
Next Earnings
May 10, 2018EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding518,347,691
10 Day Avg. Volume837,714
30 Day Avg. VolumeN/A
Standard Deviation0.38
R-Squared0.00096
Alpha-0.00811
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.33
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Innovation Pharmaceuticals News
PremiumCompany Announcements
Innovation Pharmaceuticals Inc Faces Lease Litigation Loss
PremiumCompany Announcements
Innovation Pharmaceuticals Announces Board Members’ Resignation
Ownership Overview
―
Insiders
―
Mutual Funds
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
IPIX FAQ
What was Innovation Pharmaceuticals Inc’s price range in the past 12 months?
Innovation Pharmaceuticals Inc lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Innovation Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is Innovation Pharmaceuticals Inc’s upcoming earnings report date?
Innovation Pharmaceuticals Inc’s upcoming earnings report date is May 10, 2018 which is 2389 days ago.
How were Innovation Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Innovation Pharmaceuticals Inc overvalued?
According to Wall Street analysts Innovation Pharmaceuticals Inc’s price is currently Overvalued.
Does Innovation Pharmaceuticals Inc pay dividends?
Innovation Pharmaceuticals Inc does not currently pay dividends.
What is Innovation Pharmaceuticals Inc’s EPS estimate?
Innovation Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Innovation Pharmaceuticals Inc have?
Innovation Pharmaceuticals Inc has 514,013,730 shares outstanding.
What happened to Innovation Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Innovation Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in IPIX
---
Company Description
Innovation Pharmaceuticals Inc
Innovation Pharmaceuticals, Inc. is a clinical stage biotechnology company. It focuses on the discover of small molecule drugs for hard to treat diseases, including drug-resistant cancers, psoriasis, autism, and inflammatory disease. The company's lead cancer compound, Kevetrin, is an anti-cancer drug which has demonstrated the ability in pre-clinical studies to regulate the p53 pathway and attack cancers. Innovation Pharmaceuticals was founded by Krishna Kumar Menon and Leo Ehrlich in June 20, 2007 and is headquartered in Beverly, MA.
---
---